Showing 1 - 20 results of 21 for search 'S Zeerleder', query time: 0.03s
Refine Results
-
1
-
2
Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency by KM Gasser, SS Zeerleder
Published 2002-08-01
Article -
3
Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease by Bram M. M. Kremers, Simone Birocchi, Rene van Oerle, Sacha Zeerleder, Sacha Zeerleder, Sacha Zeerleder, Sacha Zeerleder, Henri M. H. Spronk, Barend M. E. Mees, Brenda M. Luken, Hugo ten Cate, Hugo ten Cate, Hugo ten Cate, Arina J. ten Cate-Hoek, Arina J. ten Cate-Hoek
Published 2019-04-01
Article -
4
-
5
-
6
S105: ADDING AZATHIOPRINE/HYDROXYUREA PRECONDITIONING TO ALEMTUZUMAB/TBI CONDITIONING IMPROVES DONOR CHIMERISM IN MATCHED SIBLING DONOR STEM CELL TRANSPLANTATION IN ADULT SICKLE CE... by E Dovern, M Aydin, M Tang, L Suijk, C van Tuijn, S Zeerleder, M Hazenberg, B Biemond, E Nur
Published 2022-01-01
Article -
7
-
8
Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma by Christian Messerli, Gertrud Wiedemann, Naomi Porret, Michael Nagler, Katja Seipel, Barbara Jeker, Urban Novak, Sacha Zeerleder, Ulrike Bacher, Thomas Pabst
Published 2023-08-01
Article -
9
Increased Nucleosomes and Neutrophil Activation Link to Disease Progression in Patients with Scrub Typhus but Not Murine Typhus in Laos. by Daniel H Paris, Femke Stephan, Ingrid Bulder, Diana Wouters, Tom van der Poll, Paul N Newton, Nicholas P J Day, Sacha Zeerleder
Published 2015-01-01
Article -
10
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma by Alexander D. Heini, Ulrike Bacher, Naomi Porret, Gertrud Wiedemann, Myriam Legros, Denise Stalder Zeerleder, Katja Seipel, Urban Novak, Michael Daskalakis, Thomas Pabst
Published 2022-09-01
Article -
11
Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use by Sacha Zeerleder, Ruchira Engel, Tao Zhang, Dorina Roem, Gerard van Mierlo, Ineke Wagenaar-Bos, Sija Marieke van Ham, Manfred Wuhrer, Diana Wouters, Ilse Jongerius
Published 2021-01-01
Article -
12
Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19 by Tiphaine Ruggeri, Yasmin De Wit, Noëlia Schärz, Gerard van Mierlo, Anne Angelillo-Scherrer, Justine Brodard, Joerg C. Schefold, Cédric Hirzel, Ilse Jongerius, Sacha Zeerleder
Published 2023-11-01
Article -
13
GATA2 haploinsufficient patients lack innate lymphoid cells that arise after hematopoietic cell transplantation by Y. F. van Lier, Y. F. van Lier, L. Krabbendam, N. J. E. Haverkate, S. S. Zeerleder, C. E. Rutten, B. Blom, H. Spits, M. D. Hazenberg, M. D. Hazenberg, M. D. Hazenberg
Published 2022-10-01
Article -
14
Neutrophil extracellular traps in patients with pulmonary tuberculosis. by van der Meer, A, Zeerleder, S, Blok, D, Kager, L, Lede, I, Rahman, W, Afroz, R, Ghose, A, Visser, C, Zahed, A, Husain, M, Alam, K, Barua, P, Hassan, M, Tayab, M, Dondorp, A, van der Poll, T
Published 2017Journal article -
15
Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones by Alicia Rovó, Mathilde Gavillet, Mathilde Gavillet, Beatrice Drexler, Peter Keller, Jenny Sarah Schneider, Giuseppe Colucci, Yan Beauverd, Hendrika Anette van Dorland, Matthias Pollak, Adrian Schmidt, Andrea De Gottardi, Marina Bissig, Thomas Lehmann, Michel A. Duchosal, Sacha Zeerleder
Published 2023-07-01
Article -
16
The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation by Esther CW deBoer, Astrid JF Thielen, Jeroen D Langereis, Angela Kamp, Mieke C Brouwer, Nienke Oskam, Marlieke L Jongsma, April J Baral, Robbert M Spaapen, Sacha Zeerleder, Gestur Vidarsson, Theo Rispens, Diana Wouters, Richard B Pouw, Ilse Jongerius
Published 2023-01-01
Article -
17
P1530: PERITRANFUSIONAL C1-INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT-MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL. by E. C. W. de Boer, M. Jalink, L. Delvasto-Nuñes, E. M. Meulenbroek, I. Baas, S. R. Janssen, E. E. Dijkman, K. A. Gelderman, D. Wouters, M. D. Engel, M. de Haas, M.-J. Kersten, I. Jongerius, S. Zeerleder, J. M. Vos
Published 2022-06-01
Article -
18
PB2574: HEMOPHAGOCYTIC SYNDROME IN ADULTS - REAL-WORLD DATA ON MORTALITY FROM A TERTIARY REFERENCE CENTER by Tatiana Wojtovicova, Drahomir Aujesky, Stephan Jakob, Nicolas Bonadies, Hansjakob Furrer, Urban Novak, Thomas Pabst, Britta Maurer, Burkhard Möller, Roman Christian Abegglen, Aristomenis Exadaktylos, Annalisa Berzigotti, Yara Banz, Vera Ulrike Bacher, Sacha S. Zeerleder, Joerg C. Schefold, André Tichelli, Anne Angelillo-Scherrer, Alicia Rovó
Published 2023-08-01
Article -
19
Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients: A Phase II Study Focusing on the Mechanism of Graft Predominance by Burak Kalin, Mariëtte ter Borg, Rebecca Wijers, Judith A.E. Somers, Bronno van der Holt, Cornelis A.M. van Bergen, Eefke J. Petersen, Jurgen Kuball, Ellen Meijer, Nicolaas P.M. Schaap, Sacha S. Zeerleder, Annoek E. Broers, Eric Braakman, J.H. Frederik Falkenburg, Cor H.J. Lamers, Jan J. Cornelissen
Published 2019-10-01
Article -
20
P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART CO... by G. Basak, C. Peczynski, C. Koenecke, S. Terwel, Y. Cabrerizo, O. Penack, I. Moiseev, H. Schoemans, N. Fegueux, V. Potter, S. Zeerleder, I. Yakoub-Agha, M. Collin, U. Schanz, P. Dreger, D. Blaise, C. Besley, B. Glass, M. Mohty, C. Chabannon, J. Kuball, J. Snowden, A. Sureda, N. Kröger, Z. Peric
Published 2022-06-01
Article